These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33804056)

  • 1. Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
    Houshmand M; Garello F; Stefania R; Gaidano V; Cignetti A; Spinelli M; Fava C; Nikougoftar Zarif M; Galimberti S; Pungolino E; Annunziata M; Luciano L; Specchia G; Bocchia M; Binotto G; Bonifacio M; Martino B; Pregno P; Stagno F; Iurlo A; Russo S; Aime S; Circosta P; Saglio G
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual Peripheral Blood CD26
    Bocchia M; Sicuranza A; Abruzzese E; Iurlo A; Sirianni S; Gozzini A; Galimberti S; Aprile L; Martino B; Pregno P; Sorà F; Alunni G; Fava C; Castagnetti F; Puccetti L; Breccia M; Cattaneo D; Defina M; Mulas O; Baratè C; Caocci G; Sica S; Gozzetti A; Luciano L; Crugnola M; Annunziata M; Tiribelli M; Pacelli P; Ferrigno I; Usala E; Sgherza N; Rosti G; Bosi A; Raspadori D
    Front Oncol; 2018; 8():194. PubMed ID: 29900128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow Cytometry Assessment of CD26
    Raspadori D; Pacelli P; Sicuranza A; Abruzzese E; Iurlo A; Cattaneo D; Gozzini A; Galimberti S; Baratè C; Pregno P; Nicolosi M; Sorà F; Annunziata M; Luciano L; Caocci G; Moretti S; Sgherza N; Fozza C; Russo S; Usala E; Liberati MA; Ciofini S; Trawinska MM; Gozzetti A; Bocchia M
    Cytometry B Clin Cytom; 2019 Jul; 96(4):294-299. PubMed ID: 30714299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26
    Pacelli P; Santoni A; Sicuranza A; Abruzzese E; Giai V; Crugnola M; Annunziata M; Galimberti S; Iurlo A; Luciano L; Sorà F; Fava C; Bestoso E; Marzano C; Cartocci A; Defina M; Sammartano V; Cencini E; Raspadori D; Bocchia M
    Front Pharmacol; 2023; 14():1194712. PubMed ID: 37305536
    [No Abstract]   [Full Text] [Related]  

  • 5. CD26/DPP-4 in Chronic Myeloid Leukemia.
    Sicuranza A; Raspadori D; Bocchia M
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of chronic myeloid leukemia stem cells and hematopoietic stem cells by global proteomic analysis.
    Zhou S; Zhu X; Liu W; Cheng F; Zou P; You Y; Xiao Y; Guo A; Zhu X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):362-367. PubMed ID: 31767149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.
    Culen M; Borsky M; Nemethova V; Razga F; Smejkal J; Jurcek T; Dvorakova D; Zackova D; Weinbergerova B; Semerad L; Sadovnik I; Eisenwort G; Herrmann H; Valent P; Mayer J; Racil Z
    Oncotarget; 2016 May; 7(22):33016-24. PubMed ID: 27145281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNome profiling of LSC-enriched CD34
    Ruiz MS; Sánchez MB; Bonecker S; Furtado C; Koile D; Yankilevich P; Cranco S; Custidiano MDR; Freitas J; Moiraghi B; Pérez MA; Pavlovsky C; Varela AI; Ventriglia V; Sánchez Ávalos JC; Larripa I; Zalcberg I; Mordoh J; Valent P; Bianchini M
    Front Pharmacol; 2020; 11():612573. PubMed ID: 33569005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia.
    Kana S; John S; Basu D; Kar R; Nachiappa Ganesh R; Dubashi B
    Cureus; 2024 Mar; 16(3):e56944. PubMed ID: 38665755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia.
    Ito K; Ito K
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD26 expression on circulating CD34+/CD38- progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia-A single-center validation study.
    Rahman K; Singh MK; Chandra D; Gupta R; Sarkar MK; Gupta P; Gupta A; Yadav S; Kashyap R; Nityanand S
    Int J Lab Hematol; 2022 Jun; 44(3):524-530. PubMed ID: 35315228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia.
    Ebian HF; Abdelnabi AM; Abdelazem AS; Khamis T; Fawzy HM; Hussein S
    Leuk Res Rep; 2022; 17():100321. PubMed ID: 35602932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping and Target Expression Profiling of CD34
    Blatt K; Menzl I; Eisenwort G; Cerny-Reiterer S; Herrmann H; Herndlhofer S; Stefanzl G; Sadovnik I; Berger D; Keller A; Hauswirth A; Hoermann G; Willmann M; Rülicke T; Sill H; Sperr WR; Mannhalter C; Melo JV; Jäger U; Sexl V; Valent P
    Neoplasia; 2018 Jun; 20(6):632-642. PubMed ID: 29772458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
    Wang Z; Chen CC; Chen W
    Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing CML LSCs from HSCs using CD26.
    Jiang X
    Blood; 2014 Jun; 123(25):3851-2. PubMed ID: 24948622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
    Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
    Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
    Abruzzese E; Bocchia M; Trawinska MM; Raspadori D; Bondanini F; Sicuranza A; Pacelli P; Re F; Cavalleri A; Farina M; Malagola M; Russo D; De Fabritiis P; Bernardi S
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.
    Valent P; Sadovnik I; Ráčil Z; Herrmann H; Blatt K; Cerny-Reiterer S; Eisenwort G; Lion T; Holyoake T; Mayer J
    Eur J Clin Invest; 2014 Dec; 44(12):1239-45. PubMed ID: 25371066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
    Cheloni G; Tanturli M; Tusa I; Ho DeSouza N; Shan Y; Gozzini A; Mazurier F; Rovida E; Li S; Dello Sbarba P
    Blood; 2017 Aug; 130(5):655-665. PubMed ID: 28576876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro.
    Liu MY; Wang WZ; Liao FF; Wu QQ; Lin XH; Chen YH; Cheng L; Jin XB; Zhu JY
    Cell Biol Int; 2017 Jan; 41(1):16-23. PubMed ID: 27677634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.